Skip to main content

Table 3 Impact of MDA on microfilaria prevalence at spot-check sites in four endemic regions/states of Myanmar

From: Rapid progress towards elimination of lymphatic filariasis in endemic regions of Myanmar as a result of 16 years of anti-filarial activities (2001–2016)

Region/state

No of endemic IUs

Year of post-MDA survey

No. of spot-check sites

mf prevalence (range)

Overall mf prevalence (%)

No. of sites with mf

< 1%            > = 1%

Magway

04

2003

05

0.0–7.6

2.2

3

2

2004

04

0.6–2.8

1.7

1

3

2005

04

3.0–7.2

5.1

0

4

2006

04

0.2–1.4

0.6

3

1

2008

04

1.9–2.5

1.3

0

4

2009

02

0.0–0.8

0.4

2

0

2012

07

0.0–6.6

1.2

4

3

2014

01

0.6

0.6

1

0

Sagaing

06

2004

06

0.0–6.6

2.6

4

2

2007

06

0.0–5.6

2.7

1

5

2008

04

0.2–5.6

2.0

2

2

2009

06

0.0–5.6

1.5

4

2

2014

05

0.0–0.0

0.0

5

0

Mandalay

07

2011

04

0.0–3.8

1.5

2

2

2014

01

0.0

0.0

1

0

Rakhine

04

2008

04

0.0–0.6

0.3

4

0

2010

04

0.0–0.6

0.2

4

0

2015

02

0.0

0.0

2

0

  1. IU implementation unit, MDA Mass Drug Administration, mf microfilaria
  2. In Magway, MDA started in 02 IUs in 2001, later 02 more IUs were added in 2002
  3. In Sagaing MDA started in 06 IUs, later stopped in 03 IUs in 2009
  4. In Rakhine, MDA started in 04 IUs, later stopped in all 04 IUs in 2009